Systemic Immune-Inflammation Index Predicts Overall Survival in Patients with Gastric Cancer: a Propensity Score-Matched Analysis.
Gastric cancer
Overall survival
Systemic immune-inflammation index
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
04
04
2020
accepted:
22
06
2020
pubmed:
2
7
2020
medline:
29
5
2021
entrez:
2
7
2020
Statut:
ppublish
Résumé
The systemic immune-inflammation index (SII), integrated by peripheral lymphocyte, neutrophil, and platelet counts, is used as an objective biomarker that reflects the balance between host inflammatory and immune response status in cancer patients. Herein, we examined the prognostic significance of SII in gastric cancer patients. We retrospectively reviewed data of 415 patients who underwent curative laparoscopic gastrectomy using propensity score-matched (PSM) analysis. The prognostic value of SII was compared between two groups based on SII values: low SII group (SII < 661.9) and high SII group (SII ≥ 661.9). In multivariate analysis, the American Society of Anesthesiologists physical status (ASA-PS) (p < 0.001), tumor differentiation (p = 0.019), pathological stage (p = 0.046), carcinoembryonic antigen (CEA) level (p < 0.001), SII (p = 0.006), and operative procedure (p = 0.009) were independent prognostic factors of overall survival (OS) in the overall PSM cohort. The log-rank test demonstrated that patients with a high SII had significantly worse OS than did those with low SII (p = 0.002). In age-stratified subgroups analysis (< 65/≥ 65 years), multivariate analysis revealed that ASA-PS (p < 0.001), tumor differentiation (p = 0.019), CEA level (p = 0.008), SII (p = 0.013), and operative procedure (p = 0.026) were independent prognostic factors of OS in the elderly group. Similarly, elderly patients with a high SII had significantly worse OS than did those with a low SII (p = 0.009). Meanwhile, SII was not an independent prognostic factor of OS, and no significant association was observed between SII and OS in non-elderly patients. SII was an independent prognostic indicator in gastric cancer patients, especially in the elderly population.
Sections du résumé
BACKGROUND
The systemic immune-inflammation index (SII), integrated by peripheral lymphocyte, neutrophil, and platelet counts, is used as an objective biomarker that reflects the balance between host inflammatory and immune response status in cancer patients. Herein, we examined the prognostic significance of SII in gastric cancer patients.
METHODS
We retrospectively reviewed data of 415 patients who underwent curative laparoscopic gastrectomy using propensity score-matched (PSM) analysis. The prognostic value of SII was compared between two groups based on SII values: low SII group (SII < 661.9) and high SII group (SII ≥ 661.9).
RESULTS
In multivariate analysis, the American Society of Anesthesiologists physical status (ASA-PS) (p < 0.001), tumor differentiation (p = 0.019), pathological stage (p = 0.046), carcinoembryonic antigen (CEA) level (p < 0.001), SII (p = 0.006), and operative procedure (p = 0.009) were independent prognostic factors of overall survival (OS) in the overall PSM cohort. The log-rank test demonstrated that patients with a high SII had significantly worse OS than did those with low SII (p = 0.002). In age-stratified subgroups analysis (< 65/≥ 65 years), multivariate analysis revealed that ASA-PS (p < 0.001), tumor differentiation (p = 0.019), CEA level (p = 0.008), SII (p = 0.013), and operative procedure (p = 0.026) were independent prognostic factors of OS in the elderly group. Similarly, elderly patients with a high SII had significantly worse OS than did those with a low SII (p = 0.009). Meanwhile, SII was not an independent prognostic factor of OS, and no significant association was observed between SII and OS in non-elderly patients.
CONCLUSIONS
SII was an independent prognostic indicator in gastric cancer patients, especially in the elderly population.
Identifiants
pubmed: 32607856
doi: 10.1007/s11605-020-04710-7
pii: 10.1007/s11605-020-04710-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1124-1133Références
Farrow B, Sugiyama Y, Chen A, Uffort E, Nealon W, Mark Evers B. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg 2004;239:763-769; discussion 769-771.
doi: 10.1097/01.sla.0000128681.76786.07
Mimatsu K, Fukino N, Ogasawara Y, Saino Y, Oida T. Utility of inflammatory marker- and nutritional status-based prognostic factors for predicting the prognosis of stage IV gastric cancer patients undergoing non-curative surgery. Anticancer Res 2017;37:4215-4222.
pubmed: 28739709
Yun JK, McCormick TS, Villabona C, Judware RR, Espinosa MB, Lapetina EG. Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc Natl Acad Sci U S A 1997;94:13903-13908.
doi: 10.1073/pnas.94.25.13903
Hirahara N, Matsubara T, Mizota Y, Ishibashi S, Tajima Y. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy. BMC Surg 2016;16:66. doi: https://doi.org/10.1186/s12893-016-0179-5 .
doi: 10.1186/s12893-016-0179-5
pubmed: 27650456
pmcid: 5028997
Shimizu T, Taniguchi K, Asakuma M, Tomioka A, Inoue Y, Komeda K, Hirokawa F, Uchiyama K. Lymphocyte-to-monocyte ratio and prognostic nutritional index predict poor prognosis in patients on chemotherapy for unresectable pancreatic cancer. Anticancer Res 2019;39:2169-2176. doi: https://doi.org/10.21873/anticanres.13331 .
doi: 10.21873/anticanres.13331
pubmed: 30952764
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 2014;20:6212-6222.
doi: 10.1158/1078-0432.CCR-14-0442
Cancer Research UK [Internet]. Available: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics
Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009;374:477-490. doi: https://doi.org/10.1016/S0140-6736(09)60617-6 .
doi: 10.1016/S0140-6736(09)60617-6
pubmed: 19625077
pmcid: 4613761
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19. https://doi.org/10.1007/s10120-016-0622-4 .
doi: 10.1007/s10120-016-0622-4
Sobin L, Gospodarowicz M, Wittekind C, editors. International Union against Cancer (UICC). TNM classification of malignant tumors, 7th ed. New York: Wiley-Blackwell, 2010.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-196. https://doi.org/10.1097/SLA.0b013e3181b13ca2 .
doi: 10.1097/SLA.0b013e3181b13ca2
pubmed: 19638912
Dupré A, Jones RP, Diaz-Nieto R, Fenwick SW, Poston GJ, Malik HZ. Preoperative leucocyte-based inflammatory scores in patients with colorectal liver metastases: Can we count on them? World J Surg 2019;43:1351-1359. doi: https://doi.org/10.1007/s00268-019-04914-2 .
doi: 10.1007/s00268-019-04914-2
pubmed: 30673814
Xu F, Xu P, Cui W, Gong W, Wei Y, Liu B, Dong J. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid in identifying patients with non-small cell lung cancer and predicting tumor-node-metastasis stages. Oncol Lett 2018;16:483-490. doi: https://doi.org/10.3892/ol.2018.8644 .
doi: 10.3892/ol.2018.8644
pubmed: 29928436
pmcid: 6006354
Huang Z, Liu Y, Yang C, Li X, Pan C, Rao J, Li N, Liao W, Lin L. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer. BMC Cancer 2018;18:515. doi: https://doi.org/10.1186/s12885-018-4414-6 .
doi: 10.1186/s12885-018-4414-6
pubmed: 29720123
pmcid: 5932840
Lu Y, Xin D, Wang F. Predictive significance of preoperative systemic immune-inflammation index determination in postoperative liver metastasis of colorectal cancer. Onco Targets Ther 2019;20;12:7791-7799. doi: https://doi.org/10.2147/OTT.S223419 .
doi: 10.2147/OTT.S223419
Zhong JH, Huang DH, Chen ZY. Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget 2017;8:75381-75388. doi: https://doi.org/10.18632/oncotarget.18856 .
doi: 10.18632/oncotarget.18856
pubmed: 29088873
pmcid: 5650428
Wang L, Wang C, Wang J, Huang X, Cheng Y. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2017;143:2077-2086. doi: https://doi.org/10.1007/s00432-017-2451-1 .
doi: 10.1007/s00432-017-2451-1
pubmed: 28601935
Nakano Y, Uchiyama M, Arima T, Nagasaka S, Igarashi T, Shimizu A, Takahashi H. PPARα Agonist suppresses inflammation after corneal alkali burn by suppressing proinflammatory cytokines, MCP-1, and nuclear translocation of NF-κB. Molecules 2018;24. E114. doi: https://doi.org/10.3390/molecules24010114 .
doi: 10.3390/molecules24010114
pubmed: 30597991
Yang HL, Huang PJ, Liu YR, Kumar KJ, Hsu LS, Lu TL, Chia YC, Takajo T, Kazunori A, Hseu YC. Toona sinensis inhibits LPS-induced inflammation and migration in vascular smooth muscle cells via suppression of reactive oxygen species and NF-κB signaling pathway. Oxid Med Cell Longev 2014:901315. doi: https://doi.org/10.1155/2014/901315 .
Gao Z, Tong C, Wang Y, Chen D, Wu Z, Han W. Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells. J Genet Genomics 2019;46:367-377. doi: https://doi.org/10.1016/j.jgg.2019.06.007 .
doi: 10.1016/j.jgg.2019.06.007
pubmed: 31466926
Liu L, Zou J, Guan Y, Zhang Y, Zhang W, Zhou X, Xiong C, Tolbert E, Zhao TC, Bayliss G, Zhuang S. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition. FASEB J 2019;33:11941-11958. doi: https://doi.org/10.1096/fj.201801861R .
doi: 10.1096/fj.201801861R
pubmed: 31373855
Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. Eur J Cancer 2006;42:704-707.
doi: 10.1016/j.ejca.2006.01.008
Shimetani N, Shimetani K, Mori M. Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein. Scand J Clin Lab Invest 2004;64:469-474.
doi: 10.1080/00365510410006658
Saltzman RL, Peterson PK. Immunodeficiency of the elderly. Rev Infect Dis 1987; 9:1127-1139.
doi: 10.1093/clinids/9.6.1127
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883- 899.
doi: 10.1016/j.cell.2010.01.025
Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004;5:133-139.
doi: 10.1038/ni1033
Kawakami K, Kadota J, Iida K, Shirai R, Abe K, Kohno S. Reduced immune function and malnutrition in the elderly. Tohoku J Exp Med 1999;187:157-171.
doi: 10.1620/tjem.187.157
Kimbara S, Kondo S. Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma. World J Gastroenterol 2016;22:7440-7452. doi: https://doi.org/10.3748/wjg.v22.i33.7440 .
doi: 10.3748/wjg.v22.i33.7440
pubmed: 27672267
pmcid: 5011660
Huang L, Liu S, Lei Y, Wang K, Xu M, Chen Y, Fu Q, Zhang P, Qin K, Cai Y, Fu S, Ge S, Yuan X. Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection. Oncotarget 2016;7:44185-44193. doi: https://doi.org/10.18632/oncotarget.9923 .
doi: 10.18632/oncotarget.9923
pubmed: 27283904
pmcid: 5190088
Lin JX, Wang ZK, Huang YQ, Xie JW, Wang JB, Lu J, Chen QY, Lin M, Tu RH, Huang ZN, Lin JL, Zheng CH, Huang CM, Li P. Dynamic changes in pre- and postoperative levels of inflammatory markers and their effects on the prognosis of patients with gastric cancer. J Gastrointest Surg 2020. doi: https://doi.org/10.1007/s11605-020-04523-8 .
Sun Y, Huang Z, Chi P. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma. Int J Clin Oncol 2020. doi: https://doi.org/10.1007/s10147-020-01670-5 .
Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z, Zhou LD. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg 2020. doi: https://doi.org/10.1007/s11605-019-04492-7 .
Hua X, Deng JP, Long ZQ, Zhang WW, Huang X, Wen W, Guo L, He ZY, Lin HX. Prognostic significance of the skeletal muscle index and an inflammation biomarker in patients with breast cancer who underwent postoperative adjuvant radiotherapy. Curr Probl Cancer 2019;1:100513. doi: https://doi.org/10.1016/j.currproblcancer.2019.100513 .
doi: 10.1016/j.currproblcancer.2019.100513
Nishihira T, Hirayama K, Akimoto M, Sato S, Shineha R, Tan M, Kasai M. Significance of active nutritional support for maintenance of immunopotentiation on the surgical treatment of esophageal cancer. Nihon Geka Gakkai Zassi 1985;86:1104-1107.
Shirai R, Kadota J, Iida K, Kawakami K, Abe K, Yoshinaga M, Iwashita T, Matsubara Y, Oka M, Kohno S. Immunological competence and nutritional status in patients with lung cancer. Lung 1998;176:363-370.
doi: 10.1007/PL00007618